TENET HEALTHCARE CORP (THC) earnings date, results and what the price requires
NYSE · SEC CIK 0000070318 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 23, 2026 | $5.63B | — | $9.84 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $5.37B | — | $8.01 | Filing |
| Dec 31, 2025 | Feb 2, 2026 | $5.53B | — | $4.22 | Filing |
| Sep 30, 2025 | Oct 28, 2025 | $5.29B | — | $3.86 | Filing |
| Jun 30, 2025 | Jul 22, 2025 | $5.27B | — | $3.14 | Filing |
| Mar 31, 2025 | Apr 29, 2025 | $5.22B | — | $4.27 | Filing |
| Dec 31, 2024 | Feb 12, 2025 | $5.07B | — | $3.79 | Filing |
| Sep 30, 2024 | Oct 29, 2024 | $5.13B | — | $4.89 | Filing |
What would TENET HEALTHCARE CORP have to report for its valuation to change?
At $275.13, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -1.9% a year, to $23.52. On that path the next quarter needs diluted EPS near $3.79, against $3.86 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -1.9% | -1.9% |
| EPS needed in final year | $23.52 | $23.52 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. THC goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.